Samuel Mackintosh
Concepts (477)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 22 | 2025 | 313 | 2.130 |
Why?
| Proteome | 16 | 2025 | 161 | 2.080 |
Why?
| Histones | 10 | 2025 | 294 | 1.080 |
Why?
| Chromatin | 8 | 2025 | 133 | 0.870 |
Why?
| Saccharomyces cerevisiae Proteins | 7 | 2019 | 142 | 0.700 |
Why?
| DNA-Binding Proteins | 7 | 2021 | 410 | 0.660 |
Why?
| Animals | 38 | 2025 | 13063 | 0.570 |
Why?
| Viral Nonstructural Proteins | 4 | 2021 | 58 | 0.570 |
Why?
| Phosphoproteins | 3 | 2025 | 116 | 0.540 |
Why?
| Transcription Factors | 9 | 2025 | 561 | 0.520 |
Why?
| Mice | 24 | 2025 | 5659 | 0.500 |
Why?
| Saccharomyces cerevisiae | 6 | 2019 | 173 | 0.500 |
Why?
| Protein Interaction Mapping | 4 | 2020 | 37 | 0.480 |
Why?
| DNA Helicases | 3 | 2021 | 147 | 0.460 |
Why?
| Ubiquitin-Protein Ligases | 3 | 2024 | 93 | 0.430 |
Why?
| Nuclear Pore Complex Proteins | 2 | 2025 | 11 | 0.420 |
Why?
| Bacterial Proteins | 4 | 2019 | 351 | 0.410 |
Why?
| DNA | 4 | 2015 | 534 | 0.410 |
Why?
| Septins | 2 | 2024 | 18 | 0.410 |
Why?
| Cryptococcus neoformans | 2 | 2024 | 26 | 0.410 |
Why?
| Interferon Type I | 2 | 2023 | 23 | 0.390 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 134 | 0.390 |
Why?
| Hepacivirus | 3 | 2010 | 102 | 0.390 |
Why?
| Fungal Proteins | 2 | 2024 | 119 | 0.380 |
Why?
| G-Quadruplexes | 3 | 2019 | 75 | 0.370 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 36 | 0.350 |
Why?
| Melanoma | 3 | 2024 | 278 | 0.350 |
Why?
| Blood Proteins | 2 | 2024 | 83 | 0.350 |
Why?
| Protein Processing, Post-Translational | 6 | 2020 | 155 | 0.340 |
Why?
| Aging | 3 | 2024 | 692 | 0.340 |
Why?
| Virus Replication | 2 | 2015 | 141 | 0.340 |
Why?
| Protein Binding | 10 | 2021 | 648 | 0.340 |
Why?
| Tandem Mass Spectrometry | 7 | 2020 | 238 | 0.340 |
Why?
| Mass Spectrometry | 8 | 2021 | 285 | 0.340 |
Why?
| Lysine | 2 | 2023 | 84 | 0.330 |
Why?
| Signal Transduction | 8 | 2025 | 1608 | 0.320 |
Why?
| Oncogene Proteins, Fusion | 3 | 2025 | 57 | 0.320 |
Why?
| Humans | 43 | 2025 | 50419 | 0.310 |
Why?
| Proteolysis | 4 | 2023 | 96 | 0.310 |
Why?
| Kidney | 2 | 2025 | 690 | 0.300 |
Why?
| Staphylococcus aureus | 3 | 2019 | 321 | 0.290 |
Why?
| Cell Cycle Checkpoints | 2 | 2019 | 29 | 0.290 |
Why?
| Bone Resorption | 2 | 2022 | 301 | 0.270 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 173 | 0.270 |
Why?
| Osteoclasts | 2 | 2022 | 427 | 0.260 |
Why?
| Mice, Knockout | 7 | 2025 | 840 | 0.260 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2025 | 831 | 0.260 |
Why?
| HEK293 Cells | 6 | 2021 | 209 | 0.250 |
Why?
| Caenorhabditis elegans | 2 | 2016 | 131 | 0.250 |
Why?
| Gene Silencing | 2 | 2023 | 114 | 0.240 |
Why?
| DNA Replication | 1 | 2006 | 155 | 0.240 |
Why?
| Mice, Inbred C57BL | 8 | 2025 | 1796 | 0.240 |
Why?
| BRCA1 Protein | 1 | 2025 | 32 | 0.240 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 17 | 0.230 |
Why?
| Homeodomain Proteins | 2 | 2025 | 79 | 0.230 |
Why?
| Organ Preservation | 1 | 2025 | 30 | 0.230 |
Why?
| Nuclear Proteins | 2 | 2016 | 235 | 0.230 |
Why?
| Glycine | 1 | 2025 | 78 | 0.230 |
Why?
| Heart Bypass, Right | 1 | 2024 | 15 | 0.230 |
Why?
| Sirtuin 1 | 1 | 2024 | 28 | 0.230 |
Why?
| Glucuronidase | 1 | 2024 | 47 | 0.230 |
Why?
| Diastole | 1 | 2024 | 70 | 0.220 |
Why?
| Phenylalanine | 1 | 2025 | 134 | 0.220 |
Why?
| Arteriovenous Fistula | 1 | 2024 | 30 | 0.220 |
Why?
| Pulmonary Veins | 1 | 2024 | 41 | 0.220 |
Why?
| Chiroptera | 1 | 2023 | 4 | 0.220 |
Why?
| Retroelements | 1 | 2023 | 12 | 0.220 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 7 | 0.220 |
Why?
| Stress, Physiological | 1 | 2024 | 171 | 0.220 |
Why?
| Mediator Complex | 1 | 2023 | 4 | 0.220 |
Why?
| Fontan Procedure | 1 | 2024 | 70 | 0.210 |
Why?
| Membrane Proteins | 2 | 2016 | 337 | 0.210 |
Why?
| Uterine Cervical Neoplasms | 2 | 2016 | 275 | 0.210 |
Why?
| Viruses | 1 | 2023 | 21 | 0.210 |
Why?
| Cyclin-Dependent Kinases | 1 | 2023 | 26 | 0.210 |
Why?
| Arteriovenous Malformations | 1 | 2024 | 76 | 0.210 |
Why?
| Cell Cycle Proteins | 2 | 2021 | 163 | 0.210 |
Why?
| Pulmonary Artery | 1 | 2024 | 153 | 0.200 |
Why?
| Kidney Transplantation | 1 | 2025 | 189 | 0.200 |
Why?
| Polycomb Repressive Complex 2 | 2 | 2021 | 46 | 0.200 |
Why?
| Energy Metabolism | 1 | 2025 | 286 | 0.200 |
Why?
| Methionine | 1 | 2024 | 134 | 0.200 |
Why?
| NF-E2-Related Factor 2 | 1 | 2023 | 40 | 0.200 |
Why?
| Trans-Activators | 2 | 2019 | 135 | 0.200 |
Why?
| Epigenesis, Genetic | 4 | 2023 | 371 | 0.200 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 8 | 0.200 |
Why?
| Cecum | 2 | 2021 | 59 | 0.200 |
Why?
| Peripheral Nerve Injuries | 1 | 2022 | 23 | 0.200 |
Why?
| Receptors, Transferrin | 1 | 2022 | 16 | 0.200 |
Why?
| Intellectual Disability | 1 | 2024 | 121 | 0.200 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 5 | 0.200 |
Why?
| Osteogenesis Imperfecta | 2 | 2020 | 37 | 0.190 |
Why?
| Histone Acetyltransferases | 2 | 2014 | 21 | 0.190 |
Why?
| Cell Proliferation | 4 | 2021 | 980 | 0.190 |
Why?
| Mutation | 7 | 2020 | 1275 | 0.190 |
Why?
| Liver Failure, Acute | 1 | 2022 | 55 | 0.190 |
Why?
| T-Lymphocytes | 2 | 2021 | 325 | 0.190 |
Why?
| DEAD-box RNA Helicases | 2 | 2019 | 33 | 0.190 |
Why?
| Early Growth Response Protein 1 | 1 | 2021 | 34 | 0.180 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.180 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 6 | 0.180 |
Why?
| End Stage Liver Disease | 1 | 2022 | 46 | 0.180 |
Why?
| DNA-Activated Protein Kinase | 1 | 2021 | 21 | 0.180 |
Why?
| Neoplasms | 2 | 2021 | 1248 | 0.180 |
Why?
| Polycomb-Group Proteins | 1 | 2021 | 7 | 0.180 |
Why?
| Iron | 1 | 2022 | 120 | 0.180 |
Why?
| Cell Line | 5 | 2023 | 997 | 0.180 |
Why?
| Cadherins | 2 | 2019 | 61 | 0.180 |
Why?
| Uterine Artery | 1 | 2021 | 2 | 0.180 |
Why?
| Lymphocyte Activation | 1 | 2021 | 169 | 0.180 |
Why?
| Carcinoma, Hepatocellular | 1 | 2023 | 191 | 0.180 |
Why?
| Ozone | 1 | 2021 | 20 | 0.180 |
Why?
| Apoptosis | 3 | 2021 | 1092 | 0.180 |
Why?
| Transcriptional Activation | 4 | 2025 | 120 | 0.170 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 136 | 0.170 |
Why?
| Vanadates | 1 | 2020 | 8 | 0.170 |
Why?
| Phosphotyrosine | 1 | 2020 | 7 | 0.170 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 59 | 0.170 |
Why?
| Adenine | 2 | 2019 | 30 | 0.170 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 111 | 0.170 |
Why?
| Multiple Myeloma | 3 | 2021 | 2990 | 0.170 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 77 | 0.170 |
Why?
| Infant Formula | 1 | 2021 | 147 | 0.170 |
Why?
| Translocation, Genetic | 1 | 2021 | 236 | 0.160 |
Why?
| Liver Neoplasms | 1 | 2023 | 321 | 0.160 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 66 | 0.160 |
Why?
| Molecular Chaperones | 1 | 2020 | 59 | 0.160 |
Why?
| DNA Damage | 2 | 2024 | 299 | 0.160 |
Why?
| Carrier Proteins | 1 | 2021 | 297 | 0.160 |
Why?
| Alanine Transaminase | 1 | 2020 | 117 | 0.160 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 5 | 0.160 |
Why?
| Muscle, Skeletal | 1 | 2025 | 786 | 0.160 |
Why?
| Collagen Type I | 1 | 2020 | 81 | 0.160 |
Why?
| Ribonucleoproteins | 1 | 2019 | 19 | 0.160 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 180 | 0.160 |
Why?
| Protein Kinases | 1 | 2019 | 68 | 0.160 |
Why?
| Lymphoma, Mantle-Cell | 1 | 2019 | 14 | 0.160 |
Why?
| Repressor Proteins | 2 | 2019 | 149 | 0.160 |
Why?
| Ruminococcus | 1 | 2019 | 7 | 0.160 |
Why?
| Starch | 1 | 2019 | 12 | 0.160 |
Why?
| Xenopus Proteins | 1 | 2019 | 31 | 0.160 |
Why?
| Integrin alpha Chains | 1 | 2019 | 9 | 0.160 |
Why?
| Oxidative Phosphorylation | 1 | 2019 | 41 | 0.160 |
Why?
| Arsenic | 1 | 2019 | 22 | 0.160 |
Why?
| Virulence Factors | 1 | 2019 | 77 | 0.150 |
Why?
| Methylation | 4 | 2023 | 117 | 0.150 |
Why?
| Melanoma, Experimental | 1 | 2019 | 40 | 0.150 |
Why?
| Antineoplastic Agents | 3 | 2022 | 1165 | 0.150 |
Why?
| Drug Resistance, Neoplasm | 2 | 2019 | 315 | 0.150 |
Why?
| Computational Biology | 1 | 2020 | 194 | 0.150 |
Why?
| Cell Line, Tumor | 5 | 2021 | 1393 | 0.150 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2022 | 200 | 0.150 |
Why?
| Oligonucleotides | 3 | 2008 | 75 | 0.150 |
Why?
| Protein Biosynthesis | 2 | 2019 | 231 | 0.150 |
Why?
| Molecular Targeted Therapy | 1 | 2019 | 122 | 0.150 |
Why?
| Osteomyelitis | 1 | 2019 | 125 | 0.150 |
Why?
| Peptide Hydrolases | 1 | 2018 | 61 | 0.150 |
Why?
| Software | 1 | 2020 | 268 | 0.140 |
Why?
| Female | 15 | 2025 | 27053 | 0.140 |
Why?
| Antigens, CD | 1 | 2019 | 221 | 0.140 |
Why?
| Diet | 1 | 2021 | 564 | 0.140 |
Why?
| Host-Pathogen Interactions | 2 | 2016 | 134 | 0.140 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 191 | 0.140 |
Why?
| Kinetics | 4 | 2019 | 634 | 0.140 |
Why?
| Male | 12 | 2025 | 25866 | 0.140 |
Why?
| Up-Regulation | 2 | 2016 | 446 | 0.140 |
Why?
| Breast Neoplasms | 2 | 2016 | 1198 | 0.140 |
Why?
| CTLA-4 Antigen | 1 | 2017 | 22 | 0.140 |
Why?
| Histone Code | 1 | 2017 | 30 | 0.140 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 37 | 0.130 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 17 | 0.130 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 37 | 0.130 |
Why?
| RNA, Messenger | 2 | 2019 | 1085 | 0.130 |
Why?
| Neoplasm Proteins | 2 | 2016 | 320 | 0.130 |
Why?
| 3' Untranslated Regions | 1 | 2016 | 52 | 0.130 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.130 |
Why?
| Mitochondria, Liver | 1 | 2017 | 69 | 0.130 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2016 | 14 | 0.130 |
Why?
| Butadienes | 1 | 2017 | 49 | 0.130 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 293 | 0.130 |
Why?
| Mitosis | 1 | 2016 | 87 | 0.130 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 37 | 0.130 |
Why?
| Muscles | 1 | 2016 | 104 | 0.130 |
Why?
| Vesicular Transport Proteins | 1 | 2016 | 41 | 0.130 |
Why?
| Disease Models, Animal | 4 | 2024 | 1431 | 0.130 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 131 | 0.130 |
Why?
| Cytoplasmic Granules | 1 | 2016 | 24 | 0.130 |
Why?
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.130 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.130 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2017 | 111 | 0.130 |
Why?
| Lysosomes | 1 | 2016 | 83 | 0.130 |
Why?
| Cytoplasm | 1 | 2016 | 92 | 0.130 |
Why?
| Autoantigens | 1 | 2016 | 49 | 0.130 |
Why?
| Protein Structure, Tertiary | 4 | 2014 | 241 | 0.130 |
Why?
| Viral Load | 1 | 2016 | 76 | 0.120 |
Why?
| Recombinant Proteins | 3 | 2019 | 477 | 0.120 |
Why?
| Tumor Burden | 1 | 2016 | 130 | 0.120 |
Why?
| Human papillomavirus 16 | 1 | 2016 | 43 | 0.120 |
Why?
| Chromatography, Liquid | 4 | 2020 | 231 | 0.120 |
Why?
| Antigens, Viral | 1 | 2015 | 42 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 139 | 0.120 |
Why?
| Carcinogens | 1 | 2017 | 196 | 0.120 |
Why?
| Rhadinovirus | 1 | 2015 | 21 | 0.120 |
Why?
| Cell Differentiation | 4 | 2021 | 640 | 0.120 |
Why?
| Mice, SCID | 3 | 2021 | 171 | 0.120 |
Why?
| Endoplasmic Reticulum | 1 | 2016 | 117 | 0.120 |
Why?
| Proteins | 1 | 2018 | 340 | 0.120 |
Why?
| Rats | 4 | 2025 | 3262 | 0.120 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 141 | 0.120 |
Why?
| Acetylation | 3 | 2021 | 94 | 0.120 |
Why?
| Collagen | 1 | 2016 | 199 | 0.120 |
Why?
| Tetrahymena thermophila | 1 | 2014 | 3 | 0.120 |
Why?
| Heterochromatin | 1 | 2014 | 4 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 221 | 0.110 |
Why?
| Protozoan Proteins | 1 | 2014 | 29 | 0.110 |
Why?
| Genetic Loci | 1 | 2014 | 45 | 0.110 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 54 | 0.110 |
Why?
| Cells, Cultured | 4 | 2020 | 1563 | 0.110 |
Why?
| Papillomavirus Infections | 1 | 2016 | 165 | 0.110 |
Why?
| RNA | 2 | 2023 | 164 | 0.110 |
Why?
| Phosphorylation | 3 | 2023 | 520 | 0.110 |
Why?
| HeLa Cells | 3 | 2021 | 257 | 0.110 |
Why?
| Membrane Glycoproteins | 1 | 2014 | 246 | 0.110 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 460 | 0.100 |
Why?
| Lung Neoplasms | 1 | 2019 | 597 | 0.100 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 204 | 0.100 |
Why?
| Alzheimer Disease | 1 | 2016 | 316 | 0.100 |
Why?
| Gene Expression Profiling | 3 | 2023 | 1020 | 0.100 |
Why?
| DNA Methylation | 1 | 2016 | 548 | 0.090 |
Why?
| RNA Interference | 3 | 2016 | 179 | 0.090 |
Why?
| Oxidative Stress | 1 | 2016 | 770 | 0.090 |
Why?
| Ligands | 3 | 2023 | 203 | 0.090 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2019 | 326 | 0.090 |
Why?
| Animals, Newborn | 2 | 2023 | 361 | 0.090 |
Why?
| Nevus, Pigmented | 1 | 2011 | 34 | 0.090 |
Why?
| Jurkat Cells | 2 | 2021 | 26 | 0.090 |
Why?
| Enhancer Elements, Genetic | 3 | 2021 | 57 | 0.090 |
Why?
| Hypertension | 1 | 2016 | 545 | 0.090 |
Why?
| Ovarian Neoplasms | 1 | 2014 | 449 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 464 | 0.090 |
Why?
| Ubiquitination | 2 | 2024 | 42 | 0.090 |
Why?
| Gene Deletion | 3 | 2016 | 260 | 0.090 |
Why?
| Heat-Shock Response | 2 | 2020 | 25 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 3 | 2019 | 180 | 0.080 |
Why?
| Movement | 1 | 2010 | 82 | 0.080 |
Why?
| DNA, Viral | 1 | 2010 | 134 | 0.080 |
Why?
| Time Factors | 3 | 2025 | 2933 | 0.080 |
Why?
| Bacteria | 2 | 2021 | 210 | 0.080 |
Why?
| Mitochondria | 2 | 2023 | 400 | 0.080 |
Why?
| Albuminuria | 1 | 2009 | 48 | 0.080 |
Why?
| Mice, Inbred NOD | 2 | 2021 | 89 | 0.080 |
Why?
| RNA Helicases | 1 | 2008 | 30 | 0.080 |
Why?
| Virulence | 2 | 2019 | 160 | 0.080 |
Why?
| Receptors, Cell Surface | 1 | 2009 | 117 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2016 | 1369 | 0.070 |
Why?
| Acetaminophen | 2 | 2022 | 276 | 0.070 |
Why?
| Tumor Microenvironment | 2 | 2020 | 221 | 0.070 |
Why?
| DNA Copy Number Variations | 2 | 2019 | 109 | 0.070 |
Why?
| Biofilms | 2 | 2019 | 182 | 0.070 |
Why?
| Disease Progression | 2 | 2020 | 825 | 0.070 |
Why?
| Cockayne Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
| Bloom Syndrome | 1 | 2006 | 4 | 0.070 |
Why?
| Werner Syndrome | 1 | 2006 | 14 | 0.070 |
Why?
| Eukaryotic Cells | 1 | 2006 | 14 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2009 | 200 | 0.070 |
Why?
| MCF-7 Cells | 2 | 2016 | 62 | 0.070 |
Why?
| Gene Knockdown Techniques | 2 | 2016 | 104 | 0.070 |
Why?
| Rats, Sprague-Dawley | 2 | 2021 | 1556 | 0.060 |
Why?
| RNA, Small Interfering | 2 | 2018 | 208 | 0.060 |
Why?
| Skin Neoplasms | 1 | 2011 | 492 | 0.060 |
Why?
| Mutation, Missense | 2 | 2021 | 103 | 0.060 |
Why?
| Recombination, Genetic | 1 | 2006 | 102 | 0.060 |
Why?
| Cytokines | 2 | 2021 | 602 | 0.060 |
Why?
| Spectrophotometry | 1 | 2005 | 30 | 0.060 |
Why?
| Dimerization | 1 | 2005 | 50 | 0.060 |
Why?
| Crystallography, X-Ray | 1 | 2005 | 145 | 0.060 |
Why?
| Adenosine Triphosphatases | 1 | 2005 | 88 | 0.060 |
Why?
| Plasmids | 1 | 2005 | 159 | 0.060 |
Why?
| Genome, Viral | 1 | 2005 | 73 | 0.060 |
Why?
| Protein Conformation | 1 | 2005 | 163 | 0.060 |
Why?
| Rats, Inbred Lew | 1 | 2025 | 49 | 0.060 |
Why?
| Glucose Tolerance Test | 1 | 2025 | 58 | 0.060 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2019 | 51 | 0.060 |
Why?
| Cell Membrane | 1 | 2005 | 247 | 0.060 |
Why?
| Models, Molecular | 1 | 2005 | 333 | 0.060 |
Why?
| Models, Statistical | 1 | 2005 | 224 | 0.060 |
Why?
| Blotting, Western | 1 | 2005 | 575 | 0.060 |
Why?
| Jamaica | 1 | 2023 | 8 | 0.050 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 10 | 0.050 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 62 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2025 | 537 | 0.050 |
Why?
| Hepatitis B virus | 1 | 2023 | 23 | 0.050 |
Why?
| Organoids | 1 | 2023 | 36 | 0.050 |
Why?
| Genome | 1 | 2023 | 57 | 0.050 |
Why?
| Adhesins, Bacterial | 1 | 2003 | 27 | 0.050 |
Why?
| Microvessels | 1 | 2023 | 30 | 0.050 |
Why?
| Models, Biological | 1 | 2006 | 717 | 0.050 |
Why?
| Homocysteine | 1 | 2024 | 127 | 0.050 |
Why?
| Histone Deacetylases | 1 | 2023 | 51 | 0.050 |
Why?
| Sural Nerve | 1 | 2022 | 7 | 0.050 |
Why?
| DNA, Bacterial | 1 | 2003 | 165 | 0.050 |
Why?
| Nerve Regeneration | 1 | 2022 | 21 | 0.050 |
Why?
| Reference Values | 2 | 2016 | 302 | 0.050 |
Why?
| Young Adult | 3 | 2016 | 4075 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2022 | 48 | 0.050 |
Why?
| Hepatocytes | 1 | 2023 | 179 | 0.050 |
Why?
| Cytoskeleton | 1 | 2022 | 40 | 0.050 |
Why?
| Genomics | 1 | 2024 | 238 | 0.050 |
Why?
| L-Lactate Dehydrogenase | 1 | 2022 | 61 | 0.050 |
Why?
| Antiviral Agents | 1 | 2023 | 171 | 0.050 |
Why?
| Substrate Specificity | 2 | 2015 | 190 | 0.050 |
Why?
| Protein Stability | 1 | 2021 | 42 | 0.050 |
Why?
| Influenza A virus | 1 | 2021 | 17 | 0.050 |
Why?
| Vero Cells | 1 | 2021 | 46 | 0.050 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2021 | 23 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 1 | 2021 | 96 | 0.050 |
Why?
| Echocardiography | 1 | 2024 | 398 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 29 | 0.040 |
Why?
| Promoter Regions, Genetic | 2 | 2019 | 455 | 0.040 |
Why?
| Cryptococcosis | 1 | 2020 | 19 | 0.040 |
Why?
| Models, Animal | 1 | 2021 | 225 | 0.040 |
Why?
| Glycolysis | 1 | 2021 | 69 | 0.040 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 39 | 0.040 |
Why?
| Milk, Human | 1 | 2021 | 104 | 0.040 |
Why?
| Genome, Human | 1 | 2021 | 108 | 0.040 |
Why?
| Formaldehyde | 2 | 2011 | 49 | 0.040 |
Why?
| Amino Acid Motifs | 1 | 2020 | 55 | 0.040 |
Why?
| Phosphopeptides | 1 | 2020 | 6 | 0.040 |
Why?
| Swine | 1 | 2021 | 408 | 0.040 |
Why?
| Workflow | 1 | 2020 | 50 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2021 | 354 | 0.040 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 9 | 0.040 |
Why?
| Ions | 1 | 2020 | 31 | 0.040 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 37 | 0.040 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 25 | 0.040 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 97 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 84 | 0.040 |
Why?
| Cell Transformation, Neoplastic | 1 | 2021 | 182 | 0.040 |
Why?
| Databases, Genetic | 1 | 2020 | 77 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 5 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 16 | 0.040 |
Why?
| Rats, Wistar | 1 | 2020 | 222 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 19 | 0.040 |
Why?
| Placenta | 1 | 2021 | 134 | 0.040 |
Why?
| Base Sequence | 2 | 2015 | 622 | 0.040 |
Why?
| Arsenate Reductases | 1 | 2019 | 3 | 0.040 |
Why?
| Xenopus laevis | 1 | 2019 | 43 | 0.040 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2021 | 197 | 0.040 |
Why?
| Binding Sites | 2 | 2014 | 362 | 0.040 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 47 | 0.040 |
Why?
| Oocytes | 1 | 2019 | 82 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2022 | 976 | 0.040 |
Why?
| Lung | 1 | 2022 | 493 | 0.040 |
Why?
| Heart Failure | 1 | 2024 | 531 | 0.040 |
Why?
| Piperidines | 1 | 2019 | 97 | 0.040 |
Why?
| Heart Defects, Congenital | 1 | 2024 | 603 | 0.040 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 116 | 0.040 |
Why?
| Pyrazoles | 1 | 2019 | 111 | 0.040 |
Why?
| Cell Cycle | 1 | 2019 | 227 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2019 | 453 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2019 | 230 | 0.040 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 127 | 0.040 |
Why?
| Pyrimidines | 1 | 2019 | 187 | 0.040 |
Why?
| Drug Overdose | 1 | 2020 | 162 | 0.040 |
Why?
| Mitochondrial Proteins | 1 | 2018 | 87 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 78 | 0.040 |
Why?
| Dexamethasone | 1 | 2020 | 431 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 6 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 98 | 0.030 |
Why?
| Macaca mulatta | 1 | 2017 | 97 | 0.030 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 22 | 0.030 |
Why?
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.030 |
Why?
| CDC2 Protein Kinase | 1 | 2016 | 17 | 0.030 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 28 | 0.030 |
Why?
| Vinblastine | 1 | 2016 | 22 | 0.030 |
Why?
| Ribonuclease III | 1 | 2016 | 13 | 0.030 |
Why?
| Electron Transport Complex I | 1 | 2017 | 23 | 0.030 |
Why?
| Prognosis | 1 | 2022 | 1974 | 0.030 |
Why?
| Gamma Rays | 1 | 2017 | 47 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 314 | 0.030 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 51 | 0.030 |
Why?
| Tubulin Modulators | 1 | 2016 | 27 | 0.030 |
Why?
| Cyclin D1 | 1 | 2016 | 52 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2017 | 183 | 0.030 |
Why?
| Staphylococcal Infections | 1 | 2019 | 267 | 0.030 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 11 | 0.030 |
Why?
| Cluster Analysis | 1 | 2017 | 209 | 0.030 |
Why?
| Detergents | 1 | 2016 | 15 | 0.030 |
Why?
| Endosomes | 1 | 2016 | 36 | 0.030 |
Why?
| Thermodynamics | 1 | 2016 | 33 | 0.030 |
Why?
| tau Proteins | 1 | 2016 | 29 | 0.030 |
Why?
| Codon, Nonsense | 1 | 2016 | 26 | 0.030 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 20 | 0.030 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 6 | 0.030 |
Why?
| Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| Catalytic Domain | 1 | 2016 | 57 | 0.030 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 17 | 0.030 |
Why?
| X Chromosome | 1 | 2016 | 12 | 0.030 |
Why?
| Cell Survival | 1 | 2018 | 587 | 0.030 |
Why?
| Vaccines, Subunit | 1 | 2016 | 14 | 0.030 |
Why?
| Solubility | 1 | 2016 | 71 | 0.030 |
Why?
| Hydroxylation | 1 | 2016 | 61 | 0.030 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 15 | 0.030 |
Why?
| Adult | 3 | 2016 | 13561 | 0.030 |
Why?
| Mammals | 1 | 2016 | 50 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2018 | 408 | 0.030 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 37 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 12 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 64 | 0.030 |
Why?
| Hydrogen Peroxide | 1 | 2016 | 112 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 101 | 0.030 |
Why?
| Infant | 1 | 2024 | 3648 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 44 | 0.030 |
Why?
| Tissue Distribution | 1 | 2016 | 167 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 22 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 110 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 59 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2016 | 81 | 0.030 |
Why?
| Child, Preschool | 1 | 2024 | 3953 | 0.030 |
Why?
| Cell Death | 1 | 2016 | 175 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.030 |
Why?
| Lipids | 1 | 2016 | 151 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 118 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2016 | 86 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2016 | 109 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 54 | 0.030 |
Why?
| Computer Simulation | 1 | 2016 | 273 | 0.030 |
Why?
| Transfection | 1 | 2016 | 353 | 0.030 |
Why?
| Homeostasis | 1 | 2016 | 203 | 0.030 |
Why?
| Brain | 1 | 2023 | 1318 | 0.030 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 74 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 230 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 178 | 0.030 |
Why?
| N-Acetylglucosaminyltransferases | 1 | 2014 | 16 | 0.030 |
Why?
| Glycomics | 1 | 2014 | 9 | 0.030 |
Why?
| Genotype | 1 | 2016 | 525 | 0.030 |
Why?
| Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| DNA, Protozoan | 1 | 2014 | 11 | 0.030 |
Why?
| Glycosylation | 1 | 2014 | 103 | 0.030 |
Why?
| Sequence Alignment | 1 | 2014 | 115 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2014 | 65 | 0.030 |
Why?
| Meiosis | 1 | 2014 | 64 | 0.030 |
Why?
| Liver | 1 | 2020 | 1126 | 0.030 |
Why?
| Vaccination | 1 | 2016 | 275 | 0.030 |
Why?
| Pregnancy | 1 | 2021 | 2444 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2014 | 575 | 0.030 |
Why?
| Phenotype | 1 | 2016 | 736 | 0.030 |
Why?
| Molecular Sequence Data | 1 | 2014 | 760 | 0.030 |
Why?
| Case-Control Studies | 1 | 2016 | 1152 | 0.030 |
Why?
| Age Factors | 1 | 2016 | 1118 | 0.020 |
Why?
| Bone and Bones | 1 | 2016 | 481 | 0.020 |
Why?
| Child | 1 | 2024 | 6931 | 0.020 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.020 |
Why?
| Fixatives | 1 | 2011 | 12 | 0.020 |
Why?
| Tissue Fixation | 1 | 2011 | 35 | 0.020 |
Why?
| High-Throughput Screening Assays | 1 | 2011 | 35 | 0.020 |
Why?
| Paraffin Embedding | 1 | 2011 | 51 | 0.020 |
Why?
| Middle Aged | 2 | 2016 | 12579 | 0.020 |
Why?
| Fluorescein | 1 | 2010 | 8 | 0.020 |
Why?
| Streptavidin | 1 | 2010 | 16 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2010 | 39 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2010 | 47 | 0.020 |
Why?
| Staining and Labeling | 1 | 2010 | 97 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2009 | 9 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3233 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2008 | 14 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 27 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2009 | 119 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2008 | 81 | 0.020 |
Why?
| Diabetic Nephropathies | 1 | 2009 | 63 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 955 | 0.020 |
Why?
| Blood Pressure | 1 | 2009 | 525 | 0.020 |
Why?
| Consensus Sequence | 1 | 2003 | 23 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 71 | 0.010 |
Why?
| Aged | 1 | 2016 | 9738 | 0.010 |
Why?
|
|
Mackintosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|